Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study

BACKGROUND: FOLFOX (leucovorin calcium [folinic acid], fluorouracil, and oxaliplatin) combined with or without anti-VEGF therapy represents one of the primary first-line treatment options for metastatic colorectal carcinoma (mCRC). However, there is limited comparative data on the impact of anti-VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Ronen, Amar-Farkash, Shlomit, Klein-Brill, Avital, Rosenberg-Katz, Keren, Aran, Dvir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510351/
https://www.ncbi.nlm.nih.gov/pubmed/37724508
http://dx.doi.org/10.1177/10732748231202470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510351/
https://www.ncbi.nlm.nih.gov/pubmed/37724508
http://dx.doi.org/10.1177/10732748231202470

Ejemplares similares